These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer. Wallin U, Rothenberger D, Lowry A, Luepker R, Mellgren A. Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192 [Abstract] [Full Text] [Related]
16. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence. Perez RO, Habr-Gama A, São Julião GP, Proscurshim I, Fernandez LM, de Azevedo RU, Vailati BB, Fernandes FA, Gama-Rodrigues J. Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119 [Abstract] [Full Text] [Related]
19. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection. Jawitz OK, Adam MA, Turner MC, Gilmore BF, Migaly J. Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173 [Abstract] [Full Text] [Related]